| UniProt ID | COMD4_HUMAN | |
|---|---|---|
| UniProt AC | Q9H0A8 | |
| Protein Name | COMM domain-containing protein 4 | |
| Gene Name | COMMD4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 199 | |
| Subcellular Localization | Cytoplasm . Nucleus . | |
| Protein Description | May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. [PubMed: 21778237 Down-regulates activation of NF-kappa-B.] | |
| Protein Sequence | MRFRFCGDLDCPDWVLAEISTLAKMSSVKLRLLCSQVLKELLGQGIDYEKILKLTADAKFESGDVKATVAVLSFILSSAAKHSVDGESLSSELQQLGLPKEHAASLCRCYEEKQSPLQKHLRVCSLRMNRLAGVGWRVDYTLSSSLLQSVEEPMVHLRLEVAAAPGTPAQPVAMSLSADKFQVLLAELKQAQTLMSSLG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 27 | Phosphorylation | STLAKMSSVKLRLLC HHHHHHCHHHHHHHH | 21.55 | 23532336 | |
| 29 | Ubiquitination | LAKMSSVKLRLLCSQ HHHHCHHHHHHHHHH | 29.82 | - | |
| 29 | Acetylation | LAKMSSVKLRLLCSQ HHHHCHHHHHHHHHH | 29.82 | 25953088 | |
| 29 | Malonylation | LAKMSSVKLRLLCSQ HHHHCHHHHHHHHHH | 29.82 | 26320211 | |
| 39 | Ubiquitination | LLCSQVLKELLGQGI HHHHHHHHHHHCCCC | 47.67 | - | |
| 50 | Sumoylation | GQGIDYEKILKLTAD CCCCCHHHHHHHHCC | 47.30 | - | |
| 50 | 2-Hydroxyisobutyrylation | GQGIDYEKILKLTAD CCCCCHHHHHHHHCC | 47.30 | - | |
| 50 | Sumoylation | GQGIDYEKILKLTAD CCCCCHHHHHHHHCC | 47.30 | - | |
| 50 (in isoform 1) | Ubiquitination | - | 47.30 | 21890473 | |
| 50 (in isoform 2) | Ubiquitination | - | 47.30 | 21890473 | |
| 50 | Ubiquitination | GQGIDYEKILKLTAD CCCCCHHHHHHHHCC | 47.30 | 21890473 | |
| 53 (in isoform 1) | Ubiquitination | - | 47.46 | 21890473 | |
| 53 (in isoform 2) | Ubiquitination | - | 47.46 | 21890473 | |
| 53 | Ubiquitination | IDYEKILKLTADAKF CCHHHHHHHHCCCCC | 47.46 | 21906983 | |
| 53 | Acetylation | IDYEKILKLTADAKF CCHHHHHHHHCCCCC | 47.46 | 25953088 | |
| 59 (in isoform 1) | Ubiquitination | - | 50.65 | 21890473 | |
| 59 | Ubiquitination | LKLTADAKFESGDVK HHHHCCCCCCCCCHH | 50.65 | 21906983 | |
| 59 (in isoform 2) | Ubiquitination | - | 50.65 | 21890473 | |
| 59 | Ubiquitination | LKLTADAKFESGDVK HHHHCCCCCCCCCHH | 50.65 | 21890473 | |
| 100 | Ubiquitination | LQQLGLPKEHAASLC HHHCCCCHHHHHHHH | 68.15 | - | |
| 110 | Phosphorylation | AASLCRCYEEKQSPL HHHHHHHHHHHCCHH | 14.05 | 27251275 | |
| 113 | Ubiquitination | LCRCYEEKQSPLQKH HHHHHHHHCCHHHHH | 44.10 | - | |
| 113 | Acetylation | LCRCYEEKQSPLQKH HHHHHHHHCCHHHHH | 44.10 | 23749302 | |
| 115 | Phosphorylation | RCYEEKQSPLQKHLR HHHHHHCCHHHHHHH | 38.35 | 25159151 | |
| 119 | Ubiquitination | EKQSPLQKHLRVCSL HHCCHHHHHHHHHHH | 52.90 | - | |
| 125 | Phosphorylation | QKHLRVCSLRMNRLA HHHHHHHHHHHHHHC | 19.02 | 28258704 | |
| 130 | Methylation | VCSLRMNRLAGVGWR HHHHHHHHHCCCCCE | 19.30 | - | |
| 167 | Phosphorylation | EVAAAPGTPAQPVAM EEECCCCCCCCCEEE | 17.87 | 28555341 | |
| 180 | Ubiquitination | AMSLSADKFQVLLAE EEECCHHHHHHHHHH | 37.10 | 22053931 | |
| 180 (in isoform 1) | Ubiquitination | - | 37.10 | 21890473 | |
| 189 | Ubiquitination | QVLLAELKQAQTLMS HHHHHHHHHHHHHHH | 34.78 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of COMD4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COMD4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COMD4_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |